After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
NAGE belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Niagen Bioscience Inc is $477.38M. A total of 0.51 million shares were traded on the day, compared to an average of 861.75K shares.
In the most recent transaction, Lopez Carlos Luis bought 273 shares of NAGE for 7.86 per share on Mar 07 ’25. After the transaction, the SVP, General Counsel now owns 2,251 company shares. In a previous transaction on Dec 13 ’24, Jaksch Frank L Jr sold 37,161 shares at 6.19 per share. NAGE shares that Director owns now total 244,179.
Among the insiders who bought shares, Frank Jaksch Jr. acquired of 37,161 shares on Dec 13 ’24 at a per-share price of $6.19. In another insider transaction, Pamir Ozan bought 2,907 shares at $7.36 per share on Nov 22 ’24. Company shares held by the Chief Financial Officer now total 2,907.
Dividend
Paying dividends generates immediate cash flow for investors and indicates a positive outlook for the company. NAGE’s most recent ex-dividend date was $3.04 trillion when it declared a $202.52+2.2% quarterly dividend that was paid in cash on $235.85(16.5% Upside). Previously, the company paid the dividend on $503.86(29.9% Upside) with an ex-dividend date of $2.88 trillion. The NAGE stock dividend was $387.81-0.2% per share in cash.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, NAGE has a high of $9.18 and a low of $2.31.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. NAGE’s latest balance sheet shows that the firm has $28.02M in Cash & Short Term Investments as of fiscal 2021. There were $4.70M in debt and $17.61M in liabilities at the time. Its Book Value Per Share was $0.60, while its Total Shareholder’s Equity was $31.73M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NAGE is Buy with a score of 5.00.